Claritev Corporation(CTEV)Earnings, Financials & Key Ratios

CTEV•NYSE

$31.62

Price updated Jul 7, 2026

SectorHealthcare IndustryHealthcare IT Sub-IndustryPayer and Benefits Administration

AboutClaritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services that reduce medical costs, through data-driven algorithms and insights that detect claims over-charges and negotiate or recommend reimbursement; and network-based services that provide contracted discounts with healthcare providers, as well as outsourced network development and management services. It provides payment and revenue integrity services, such as identifying and removing improper and unnecessary charges paid during the claim, as well as services to identify and help restore and preserve underpaid premium dollars. In addition, the company offers data and decision science services including a suite of solutions that apply modern methods of data science to produce descriptive, predictive, and prescriptive analytics that drive optimized benefit plan design, support decision-making, improve clinical outcomes, and reduce the total cost of care; and business-to-business healthcare payments and other services. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, self-insured health plans, property and casualty insurers, bill review companies, and other companies involved in the claim adjudication process. The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025. Claritev Corporation was founded in 1980 and is headquartered in New York, New York.Show more

Revenue$965M+3.7%
EBITDA$494M+151.8%
Net Income-$284M+82.7%
EPS (Diluted)-17.30+83.0%
Gross Margin27.61%-62.8%
EBITDA Margin51.12%+149.9%
Operating Margin4.67%+103.1%
Net Margin-29.45%+83.3%

CTEV Price & Volume

Claritev Corporation (CTEV) stock price & volume — 10-year historical chart

Loading chart...

Leverage Overhang and Margin Volatility Threaten Solvency

Investment Thesis • Updated 2026Q1

VerdictNegative

Growth:Mixed

Profitability:Negative

Financial:Vulnerable

Cash Flow:Burning

Primary Risk:Insolvency and debt overhang

Key Thesis Takeaways

Claritev Corporation faces a precarious outlook as its legacy PPO business struggles with stagnant revenue growth, which peaked at only 6.7% in 2025Q3.
The company's massive $4.6 billion debt load, coupled with a negative equity position of $241.1 million as of 2026Q1, severely restricts its ability to pivot toward modern data analytics.
Investors should remain cautious as the combination of persistent net losses and a dwindling cash reserve of $21.3 million suggests significant insolvency risk.

Verdict Logic

the company's inability to generate consistent profitability, highlighted by a -30.1% net margin in 2026Q1, makes the current capital structure unsustainable.

CTEV Growth Metrics

Claritev Corporation (CTEV) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-

5 Years0.58%

3 Years-3.66%

TTM5.53%

Profit CAGR

10 Years-

5 Years-

3 Years-

TTM75.67%

EPS CAGR

10 Years-

5 Years-

3 Years-

TTM76.23%

Return on Capital

10 Years-2.51%

5 Years-4.09%

3 Years-6.81%

Last Year0.94%

CTEV Recent Earnings

Claritev Corporation (CTEV) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 3/8 qtrs (38%)●Beat Revenue 5/8 qtrs (71%)

Q2 2026Latest

May 7, 2026

Metric

Actual

Est

EPS

$4.41-15.7%

$3.81

Rev

$245M+3.5%

$236M

Q1 2026

Feb 23, 2026

Metric

Actual

Est

EPS

$4.88-674.1%

$0.85

Rev

$247M+2.2%

$241M

Q4 2025

Nov 7, 2025

Metric

Actual

Est

EPS

$4.07-30.4%

$3.12

Rev

$246M+2.0%

$241M

Q3 2025

Aug 6, 2025

Metric

Actual

Est

EPS

$0.32+111.9%

$2.69

Rev

$242M+4.1%

$232M

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q2 2026Latest	May 7, 2026	$4.41vs $3.81-15.7%	$245Mvs $236M+3.5%
Q1 2026	Feb 23, 2026	$4.88vs $0.85-674.1%	$247Mvs $241M+2.2%
Q4 2025	Nov 7, 2025	$4.07vs $3.12-30.4%	$246Mvs $241M+2.0%
Q3 2025	Aug 6, 2025	$0.32vs $2.69+111.9%	$242Mvs $232M+4.1%

Based on last 8 quarters of dataView full earnings history →

Latest CTEV News

Recent stock market news and headlines for Claritev Corporation (CTEV)

Business Wire·Jun 23, 2026

Claritev Corporation Announces Participation in Truist Securities Healthcare Disruptors & Digital Health Conference

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced that members of its management team will participate in the Truist Securities Healthcare Disruptors & Digital Health Conference, including a panel discussion titled “The Data Before the AI: Building the Foundation for Scalable Healthcare Intelligence” with Michael Kim.

Peers Comparison

Key metrics vs top competitors for Claritev Corporation (CTEV)

Full Screener →

Company	Price	Market Cap	P/E Ratio	Rev Growth (1Y)	Net Margin	ROE	Div Yield
CTEVClaritev CorporationCurrent	$31.62	$539.05M	-1.83	3.74%	-29.45%	—	—
EHTHeHealth, Inc.	$1.62	$50.34M	-4.76	4.06%	6.31%	3.99%	—
HIMSHims & Hers Health, Inc.	$36.17	$7.94B	70.92	59%	-0.56%	-2.48%	—
TDOCTeladoc Health, Inc.	$9.10	$1.64B	-7.98	-1.54%	-6.81%	-12.37%	—
EXLSExlService Holdings, Inc.	$27.84	$4.35B	18.08	13.56%	11.66%	27.16%	—
PGNYProgyny, Inc.	$30.78	$2.41B	47.35	10.4%	5.23%	13.34%	—

Compare CTEV vs Peers

Claritev Corporation (CTEV) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs EHTH

Most directly comparable listed peer for CTEV.

Scale Benchmark

vs UNH

Larger-name benchmark to compare CTEV against a more recognizable public peer.

Peer Set

Compare Top 5

vs EHTH, HIMS, TDOC, EXLS

CTEV SEC Filings & Documents

Claritev Corporation (CTEV) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

May 7, 2026·SEC

Material company update

Apr 30, 2026·SEC

Material company update

Mar 16, 2026·SEC

10-K Annual Reports

FY 2026

Feb 26, 2026·SEC

10-Q Quarterly Reports

FY 2026

May 7, 2026·SEC

FY 2025

Nov 7, 2025·SEC

FY 2025

Aug 7, 2025·SEC

Get notified when CTEV posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

CTEV Frequently Asked Questions

Claritev Corporation (CTEV) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

What is Claritev Corporation's revenue?

Claritev Corporation (CTEV) reported $978.8M in revenue for fiscal year 2025. This represents a 0% decrease from $982.9M in 2019.

How fast is Claritev Corporation growing?

Claritev Corporation (CTEV) grew revenue by 3.7% over the past year. Growth has been modest.

Is CTEV profitable?

Claritev Corporation (CTEV) reported a net loss of $286.5M for fiscal year 2025.

Dividend & Returns

What is Claritev Corporation's free cash flow?

Claritev Corporation (CTEV) had negative free cash flow of $38.8M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in CTEV back in 2019?

Total return calculator · dividends reinvested · 7+ years of data

See returns →

Quarter

Date

EPS (Act vs Est)

Revenue (Act vs Est)

Q2 2026Latest

May 7, 2026

$4.41vs $3.81-15.7%

$245Mvs $236M+3.5%

Q1 2026

Feb 23, 2026

$4.88vs $0.85-674.1%

$247Mvs $241M+2.2%

Q4 2025

Nov 7, 2025

$4.07vs $3.12-30.4%

$246Mvs $241M+2.0%

Q3 2025

Aug 6, 2025

$0.32vs $2.69+111.9%

$242Mvs $232M+4.1%

Company

Price

Market Cap

P/E Ratio

Rev Growth (1Y)

Net Margin

ROE

Div Yield

CTEVClaritev CorporationCurrent

$31.62

$539.05M

-1.83

3.74%

-29.45%

—

EHTHeHealth, Inc.

$1.62

$50.34M

-4.76

4.06%

6.31%

3.99%

—

HIMSHims & Hers Health, Inc.

$36.17

$7.94B

70.92

59%

-0.56%

-2.48%

—

TDOCTeladoc Health, Inc.

$9.10

$1.64B

-7.98

-1.54%

-6.81%

-12.37%

—

EXLSExlService Holdings, Inc.

$27.84

$4.35B

18.08

13.56%

11.66%

27.16%

—

PGNYProgyny, Inc.

$30.78

$2.41B

47.35

10.4%

5.23%

13.34%

—